Marie Lundholm

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Correction: Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Correction: Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Journal: Scientific reports
Published: July 15, 2026

MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.

MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.

Journal: Scientific reports
Published: January 29, 2026

Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.

Journal: Scientific reports
Published: January 14, 2026

Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis.

Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis.

Journal: Clinical & experimental metastasis
Published: April 10, 2025

Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.

Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.

Journal: International journal of immunopathology and pharmacology
Published: March 07, 2023

Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.

Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.

Journal: Cancers
Published: February 15, 2023

Rat prostate tumors induce DNA synthesis in remote organs.

Rat prostate tumors induce DNA synthesis in remote organs.

Journal: Scientific reports
Published: October 25, 2021

Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.

Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.

Journal: Molecular oncology
Published: July 09, 2021

High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer.

High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer.

Journal: Cancers
Published: April 20, 2021

High-grade tumours promote growth of other less-malignant tumours in the same prostate.

High-grade tumours promote growth of other less-malignant tumours in the same prostate.

Journal: The Journal of pathology
Published: October 21, 2020

A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer.

A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer.

Journal: Cancers
Published: October 16, 2020

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.

Journal: The Prostate
Published: June 27, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026